Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

IPL-576092, a novel antiinflammatory agent, safe and well tolerated in phase I trials

May 25, 2001

In vitro and animal studies support further development of EPI-HNE-4 for CF

May 25, 2001

Ariflo highlighted at ATS meeting as promising COPD therapy

May 25, 2001

Antiallergic agent codeveloped by Tanabe Seiyaku and Ube licensed for Korean market

May 25, 2001

Viozan produces rapid and sustained activation of D2 receptors and beta2-adrenoceptors

May 24, 2001

Pharmacological profile of Ono-6818, an orally active HNE inhibitor, discussed at ATS meeting

May 24, 2001

Tryptase inhibitors designed by Boehringer Ingelheim

May 23, 2001

Alliance's LiquiVent does not reach phase II/III endpoint

May 23, 2001

SciClone's CPX for cystic fibrosis assigned orphan drug status in E.U.

May 23, 2001

ATS 2001: AWD-12-281 has beneficial effects on mucus secretion and lung neutrophilia

May 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...